Ovid Therapeutics (OVID) Stock Price

$0.29 0%

Sign up
to add to portfolio

AI Score

Sell

  • Alternative

    2

  • Fundamental

    2

  • Technical

    3

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Ovid Therapeutics, AI stock picks, stock alerts and much more.

Sign up

OVID AI Stock Analysis

AI stock analysis for OVID is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Ovid Therapeutics (OVID) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Ovid Therapeutics (OVID) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Ovid Therapeutics (OVID), currently trading at $0.29, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About OVID

LSE

  • Ovid Therapeutics Inc.

  • Symbol

    OVID

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    20.6M

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX		 $23.37
2.7%
6
INO Inovio Pharmaceuticals
INO		 $1.8
1.1%
1
MRNA Moderna
MRNA		 $24.25
0.5%
3
AVXL Anavex Life Sciences
AVXL		 $8.25
3.6%
5
BBIO BridgeBio Pharma
BBIO		 $34.17
2%
6

News

Ovid Therapeutics (OVID) Reports Q4 Loss, Lags Revenue Estimates

Ovid Therapeutics (OVID) Reports Q4 Loss, Lags Revenue Estimates
March 11, 2025. zacks.com
Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results

Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results
March 11, 2025. globenewswire.com
Ovid Therapeutics (OVID) Reports Q3 Loss, Tops Revenue Estimates

Ovid Therapeutics (OVID) Reports Q3 Loss, Tops Revenue Estimates
November 12, 2024. zacks.com

OVID Alternative Data

Web Traffic

Ovid Therapeutics receives an estimated 2788 monthly visitors to ovidrx.com, which is down by -50.3% over the last month.

  • Web Traffic

    2788

  • Change from Previous Month

    50.3%

  • 3 Month Change

    44%

  • YoY Change

    44%

Twitter Followers

Ovid Therapeutics has 1,580 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.2% over the last month.

  • Twitter Followers

    1580

  • Daily Change

    0.1%

  • 1 Month Change

    0.2%

  • 3 Month Change

    0.7%

  • YoY Change

    0.7%

Facebook Engagement

Ovid Therapeutics has engaged 0 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    100%

  • YoY Change

    100%

Youtube Subscribers

Ovid Therapeutics has 521 subscribers on its main Youtube channel, down by -0.2% over the last month.

  • Youtube Subscribers

    521

  • Daily Change

    0%

  • 1 Month Change

    0.2%

  • 3 Month Change

    0.4%

  • YoY Change

    0.4%

LinkedIn Followers

17,706 are following Ovid Therapeutics on LinkedIn, up by 0.6% over the last month.

  • LinkedIn Followers

    17706

  • Daily Change

    0%

  • 1 Month Change

    0.6%

  • 3 Month Change

    2.1%

Job Postings

Ovid Therapeutics currenly has an estimated 0 open job postings.

  • Job Postings

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

LinkedIn Employees

According to LinkedIn, Ovid Therapeutics has 42 employees.

  • LinkedIn Employees

    42

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    2.4%

  • YoY Change

    2.4%

Instagram Followers

Ovid Therapeutics has 596 Instagram Followers on its main Instagram account, down by -0.5% over the last month.

  • Instagram Followers

    596

  • Daily Change

    0%

  • 1 Month Change

    0.5%

  • 3 Month Change

    0.7%

  • YoY Change

    0.7%

News Mentions

Ovid Therapeutics was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    100%

Reddit Mentions

Ovid Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Business Outlook

According to employee reviews, the business outlook among employees at Ovid Therapeutics is 52 out of 100 (neutral).

  • Business Outlook

    52

  • Change from Previous Month

    1.9%

  • 3 Month Change

    0%

  • YoY Change

    0%

OVID Financials

OVID Key Metrics

  • Total Revenue

    $76K

  • Net Income

    -$9.3M

  • Earnings per Share

    -$0.13

  • Free cash flow

    -$10M

  • EBITDA

    -$10.6M

  • EBITDA Ratio

    -138.961

  • Total Assets

    $92.2M

OVID 2-year Revenue & Income
OVID 2-year Free Cash Flow

OVID Technicals

OVID SMA
OVID RSI

FAQ

What's the current price of Ovid Therapeutics (OVID) Stock?
The price of an Ovid Therapeutics (OVID) share is $0.29.

What's the market cap of Ovid Therapeutics?
The current market cap of Ovid Therapeutics is 20.6M.

Should I buy or sell OVID?
Ovid Therapeutics exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.

Is Ovid Therapeutics a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Ovid Therapeutics stock. There are several bearish signals and market challenges that could negatively impact Ovid Therapeutics' future performance, suggesting that caution should be exercised before making any investment decisions.

Is now a good time to buy Ovid Therapeutics (OVID) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Ovid Therapeutics stock right now, as the outlook appears bearish.

What are some stocks similar to Ovid Therapeutics (OVID) that investors often compare it to?
Ovid Therapeutics (OVID) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Ovid Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Ovid Therapeutics' stock price to be around $0.259 in 2026. Starting from the current price of $0.29, this represents a 10.7% change in price, indicating a bearish outlook for the stock.

How to buy Ovid Therapeutics (OVID) Stock?
Ovid Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Ovid Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.